Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190803044415N1Phase 2Completed
Phase 2, open-label trial of lidocaine (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Pressure pain threshold and Pain during injection. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190803044415N1.